| 标题 |
Ritlecitinib (PF-06651600), an oral JAK3/TEC inhibitor, stabilizes active lesions and promotes re-pigmentation of stable lesions in patients with active nonsegmental vitiligo: results from a phase 2b, randomized, placebo-controlled, dose-ranging study |
| 网址 | |
| DOI | |
| 其它 |
期刊:British Journal of Dermatology 作者:Yuji Yamaguchi; Elena Peeva; Ronald Shore; George Han; Lori Ann Cox; et al 出版日期:2023 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)